
AI Maps Tumors for Radiation Therapy—But Should We Trust It?
How tumor segmentation AI improves radiation precision, cuts errors, and balances trust concerns. Learn risks, benefits, and real-world onc…

How tumor segmentation AI improves radiation precision, cuts errors, and balances trust concerns. Learn risks, benefits, and real-world onc…

New research reveals CD4 T lymphocytes' surprising antitumor potential beyond traditional killer cell therapies, reshaping cancer care.

Only 1 in 10 adults realize testicular cancer mostly affects men under 40. Get crucial info on symptoms, risks, early detection, and surviv…

Eligible Aussies start lung cancer screening in July. Learn your risk level, process steps, and why early detection matters without fear.

A new precision oncology Organ Chip platform predicts chemotherapy effectiveness for esophageal adenocarcinoma, offering 100% accuracy in p…

In 2025, urine tumor DNA testing improves bladder cancer treatment choices, predicting recurrence risk and avoiding invasive surgery. Disco…

Chemoimmunotherapy for lung cancer in Stage III NSCLC shows improved tumor shrinkage, surgery options, and 30-month PFS in new Dana-Farber …

How medical students are narrowing Rural Cancer Care gaps in Montana and BC with mobile clinics, survivorship tech, and scalable follow-up …

BCG therapy receives a novel fungal molecule upgrade to improve bladder cancer immunotherapy outcomes. Learn how this 2025 advancement impa…

Recent research uncovers saliva cancer risk markers for non-invasive screening. Learn about molecular testing progress, practical limitatio…

Chromosomal imbalances in cancer cells cause protein overload, disrupting mitochondrial function. Study reveals new treatment paths for tar…

The FDA approved Monjuvi (tafasitamab-cxix) plus rituximab and lenalidomide for adult patients with relapsed/refractory follicular lymphoma.
General information only — not medical advice. Always consult a qualified healthcare professional about your own situation.